Pure Global AI
NCT06088810Not yet recruiting

The Impact of Music Intervention on Sleep

The Impact of Music Intervention on Sleep: CoMPoSER Trial
Rutgers, The State University of New JerseyClinicalTrials.govother
Verified
Study focus
Disease/Condition
Dementia
Drug/Device/Intervention
CoMPoSER intervention group
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Rutgers, The State University of New Jersey
Timeline & enrollment
Phase
N/A
Start date
Jun 01, 2024
End date
Aug 01, 2026
Enrollment
144 participants
Primary outcome

Acceptability

Summary

The primary purpose of this Stage 1b NIH-funded clinical trial (K23AG073618, PI Petrovsky) is
 to determine the efficacy of a 1-month music intervention (Calming Music Personalized for
 Sleep Enhancement in PeRsons living with Dementia, CoMPoSER) on health outcomes in 72 dyads
 (144 participants) of persons living with dementia (PLWD) and their caregivers (Stage 1b).
 The secondary purpose of this research project is to examine the mechanism of stress
 reduction and sustained effects of the music intervention on PLWD and caregiver well-being.
 We will evaluate the acceptability of the mobile application CoMPoSER in a pilot RCT and
 determine the impact of the mobile application CoMPoSER on PLWD (sleep latency, sleep
 efficiency, wake after sleep onset, total sleep time, sleep quality) and caregiver (perceived
 stress and well-being) outcomes.

ICD-10 classifications
Unspecified dementiaAlzheimer diseaseDementia in Alzheimer diseaseDementia in Alzheimer disease, unspecifiedDementia in other diseases classified elsewhere
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06088810
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06088810 through Pure Global AI's free database. This phase not specified trial is sponsored by Rutgers, The State University of New Jersey and is currently Not yet recruiting. The study focuses on Dementia. Target enrollment is 144 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.